These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 7868955

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T, Kaur I, Kumar B, Radotra BD, Dogra S.
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V, Saha B, Hajra SK, Biswas SK, Saha K.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [Abstract] [Full Text] [Related]

  • 7. Persister studies in leprosy patients after multi-drug treatment.
    Gupta UD, Katoch K, Singh HB, Natrajan M, Katoch VM.
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):100-4. PubMed ID: 16830652
    [Abstract] [Full Text] [Related]

  • 8. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
    Rea TH.
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
    [Abstract] [Full Text] [Related]

  • 9. A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy.
    Fajardo TT, Guinto RS, Cellona RV, Abalos RM, Dela Cruz EC, Gelber RH.
    Am J Trop Med Hyg; 2006 Mar; 74(3):457-61. PubMed ID: 16525107
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A clinical trial of minocycline in lepromatous leprosy.
    Gelber RH, Fukuda K, Byrd S, Murray LP, Siu P, Tsang M, Rea TH.
    BMJ; 1992 Jan 11; 304(6819):91-2. PubMed ID: 1737148
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Borderline lepromatous leprosy in an Italian man.
    Massone C, Clapasson A, Nunzi E.
    Am J Trop Med Hyg; 2013 Feb 11; 88(2):211. PubMed ID: 23390219
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy.
    Ji B, Jamet P, Perani EG, Bobin P, Grosset JH.
    J Infect Dis; 1993 Jul 11; 168(1):188-90. PubMed ID: 8257487
    [Abstract] [Full Text] [Related]

  • 19. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I, Cartel JL, Grosset JH.
    Int J Lepr Other Mycobact Dis; 1997 Jun 11; 65(2):224-9. PubMed ID: 9251595
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.